Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.
about
Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Two-Year Follow-Up Analysis of ...... ep towards Modern HCV Therapy.
@en
type
label
Two-Year Follow-Up Analysis of ...... ep towards Modern HCV Therapy.
@en
prefLabel
Two-Year Follow-Up Analysis of ...... ep towards Modern HCV Therapy.
@en
P2093
P2860
P356
P1476
Two-Year Follow-Up Analysis of ...... ep towards Modern HCV Therapy.
@en
P2093
Dennis Eurich
Fritz Klein
Jörg Hofmann
Marcus Bahra
Ruth Neuhaus
Sandra Bayraktar
P2860
P304
P356
10.1155/2016/8325467
P577
2016-04-18T00:00:00Z